Central Bank of the Republic of Turkey in the 1930s: Financials and Economic Impacts
Accounting Historians Journal · 01.05.2026 · 1-28
DOI: 10.2308/aahj-2025-009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Accounting Historians Journal, online erschienen am 26.05.2026. Verfasst von Recep Pekdemir und 3 weiteren Autor:innen.
Abstract (Originalsprache)
More than a century has passed since the collapse of the Ottoman Empire and the establishment of the Republic of Turkey. The early Republic faced some of the most challenging economic periods. This study examines the Central Bank of the Republic of Turkey’s (CBRT’s) monetary measures and their relationship with macroeconomic performance between 1933 and 1939. Using panel data and correlation heatmap analyses, the findings reveal strong positive relationships among gross domestic product (GDP), CBRT’s monetary assets, liabilities, and gold reserves, suggesting that asset management supported economic growth. Price stability was a critical factor because rising price levels are correlated with slower growth and lower CBRT profits. The results highlight the role of the CBRT in balancing growth, liquidity, and stability during the formative years of Turkey’s financial system, offering a promising outlook for the future. JEL Classifications: M40; M48.
Zitieren
APA
Pekdemir, R., Aslan, Ü., Önder, E., & Ercan, M. (2026). Central Bank of the Republic of Turkey in the 1930s: Financials and Economic Impacts. Accounting Historians Journal, 1-28. https://doi.org/10.2308/aahj-2025-009
Vancouver
Pekdemir R, Aslan Ü, Önder E, Ercan M. Central Bank of the Republic of Turkey in the 1930s: Financials and Economic Impacts. Accounting Historians Journal. 2026:1-28. doi:10.2308/aahj-2025-009
BibTeX
@article{Pekdemir2026,
author = {Pekdemir, Recep and Aslan, Ümmühan and Önder, Emrah and Ercan, Melis},
title = {Central Bank of the Republic of Turkey in the 1930s: Financials and Economic Impacts},
journal = {Accounting Historians Journal},
year = {2026},
pages = {1--28},
doi = {10.2308/aahj-2025-009}
}
EUVIMED